A, P., M, G., C, C., E, S., M, O., & F, F. (2016). Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines. Current cancer drug targets, 16(4), 373. https://doi.org/10.2174/1568009615666150817120931
Chicago Style (17th ed.) CitationA, Papi, Govoni M, Ciavarella C, Spisni E, Orlandi M, and Farabegoli F. "Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines." Current Cancer Drug Targets 16, no. 4 (2016): 373. https://doi.org/10.2174/1568009615666150817120931.
MLA (9th ed.) CitationA, Papi, et al. "Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines." Current Cancer Drug Targets, vol. 16, no. 4, 2016, p. 373, https://doi.org/10.2174/1568009615666150817120931.